Overview of the regulatory approval of tecovirimat intravenous formulation for treatment of smallpox: potential impact on smallpox outbreak response capabilities, and future tecovirimat development potential.

Saved in:
Bibliographic Details
Title: Overview of the regulatory approval of tecovirimat intravenous formulation for treatment of smallpox: potential impact on smallpox outbreak response capabilities, and future tecovirimat development potential.
Authors: Russo AT; SIGA Technologies, Inc, Corvallis, OR, USA., Grosenbach DW; SIGA Technologies, Inc, Corvallis, OR, USA., Honeychurch KM; SIGA Technologies, Inc, Corvallis, OR, USA., Long PG; SIGA Technologies, Inc, Corvallis, OR, USA., Hruby DE; SIGA Technologies, Inc, Corvallis, OR, USA.
Source: Expert review of anti-infective therapy [Expert Rev Anti Infect Ther] 2023 Mar; Vol. 21 (3), pp. 235-242. Date of Electronic Publication: 2023 Feb 02.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101181284 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8336 (Electronic) Linking ISSN: 14787210 NLM ISO Abbreviation: Expert Rev Anti Infect Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36728515
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Overview of the regulatory approval of tecovirimat intravenous formulation for treatment of smallpox: potential impact on smallpox outbreak response capabilities, and future tecovirimat development potential.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Russo+AT%22">Russo AT</searchLink>; SIGA Technologies, Inc, Corvallis, OR, USA.<br /><searchLink fieldCode="AU" term="%22Grosenbach+DW%22">Grosenbach DW</searchLink>; SIGA Technologies, Inc, Corvallis, OR, USA.<br /><searchLink fieldCode="AU" term="%22Honeychurch+KM%22">Honeychurch KM</searchLink>; SIGA Technologies, Inc, Corvallis, OR, USA.<br /><searchLink fieldCode="AU" term="%22Long+PG%22">Long PG</searchLink>; SIGA Technologies, Inc, Corvallis, OR, USA.<br /><searchLink fieldCode="AU" term="%22Hruby+DE%22">Hruby DE</searchLink>; SIGA Technologies, Inc, Corvallis, OR, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101181284%22">Expert review of anti-infective therapy</searchLink> [Expert Rev Anti Infect Ther] 2023 Mar; Vol. 21 (3), pp. 235-242. <i>Date of Electronic Publication: </i>2023 Feb 02.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101181284 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-8336 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214787210%22">14787210 </searchLink><i>NLM ISO Abbreviation: </i>Expert Rev Anti Infect Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36728515
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/14787210.2023.2170350
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 235
    Titles:
      – TitleFull: Overview of the regulatory approval of tecovirimat intravenous formulation for treatment of smallpox: potential impact on smallpox outbreak response capabilities, and future tecovirimat development potential.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Russo AT
      – PersonEntity:
          Name:
            NameFull: Grosenbach DW
      – PersonEntity:
          Name:
            NameFull: Honeychurch KM
      – PersonEntity:
          Name:
            NameFull: Long PG
      – PersonEntity:
          Name:
            NameFull: Hruby DE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2023 Mar
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1744-8336
          Numbering:
            – Type: volume
              Value: 21
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Expert review of anti-infective therapy
              Type: main
ResultId 1